表纸
年间契约型资讯服务

新药研发产品线资料库:年度订阅

R&D Drug Pipeline Database: 1-Year Subscription

出版商 La Merie Publishing 商品编码 302689
出版日期 年间契约型资讯服务 内容资讯 英文
价格
新药研发产品线资料库:年度订阅 R&D Drug Pipeline Database: 1-Year Subscription
出版日期: 年间契约型资讯服务内容资讯: 英文
简介

本年度资讯服务可全天候在线点阅关于市场上新药研发的23,400多个项目计划和研发中的候选研究药物信息。刊载各计划标的·化合物类别·产品类型·开发企业·地区·治疗领域·适应症·开发阶段等的详细资料。

本资料库的优点

  • 可直觀利用
  • 可24小时线上查询
  • 支援结构搜寻
  • 专注于目标,产品类别和研发阶段
  • 竞争对手分析的理想选择(公司,目标,产品类别)
  • 经济高效且快速的基准测试解决方案
  • 确定候选许可证

刊载项目

  • 药品编码
  • 标的/ 作用机制
  • 化合物类别
  • 产品类型
  • 企业
  • 领域
  • 治疗领域
  • 适应症
  • R&D阶段

产品类型

  • 抗体
  • 细胞
  • DNA
  • 胜肽
  • 蛋白质
  • RNA
  • 小分子
  • 疫苗

治疗领域

  • 心脏血管·血液·急性期治疗
  • 皮肤科
  • 消化器官科
  • 尿生殖器·妇产科·肾脏
  • 感染疾病·毒素
  • 代谢·内分泌系
  • 神经·神经科
  • 癌症
  • 眼科·耳鼻喉科
  • 整形外科·牙科·麻醉·外科
  • 肺·呼吸系统
  • 类风湿和自身免疫

标的:事前设定下拉滚动选单范例

  • 抗体药物复合体 (ADC)
  • 抗体·蛋白质的销售额
  • 细胞内标的 (MAGE-A·NY-ESO-1·PRAME等)
  • 免疫肿瘤标的 (PD-1·PD-L1·CTLA-4·LAG-3,TIM-3·4-1BB·CD73等)
  • CAR&TCR改变T细胞·NK细胞
  • Adalimumab (Humira) 生物相似药
  • Her2抗体
  • 双特异性抗体
  • 肿瘤溶解性病毒 (腺病毒·牛痘·HSV等)
  • 伊波拉病毒疫苗·治疗药
  • 凝血因子
  • 肉毒杆菌神经毒素
  • PTH-R受体激动剂
  • 心脏代谢胜肽

技术:事前设定下拉滚动选单范例

  • 转基因XenoMouse抗体
  • T细胞重定向双特异性抗体
  • 受体激动剂抗体
  • TCR样抗体·融合蛋白质
  • ADC (抗体药物复合体):吡咯并苯并二氮杂卓(PBD)
  • FC融合蛋白质
  • oligo·多株抗体
目录
Product Code: LMDB0004

Subscription to La Merie Publishing's proprietary ‘R&D Drug Pieline Database’ provides 24/7 online access to information about more than 25,500 project entries (files) for therapeutic drugs on the market and on investigational drug candidates in research & development. Pre-established and free search functions allow to identify molecules according to their

  • Product category (NCE, antibodies, proteins, DNA, RNA, cells, vaccines, peptides)
  • Technology (e.g.engineered T-cells, antibody-drug conjugate, bispecific antibody)
  • Target (e.g. Her2, BCMA, PD-1, RORgamma)
  • Pipelines (selected by target, therapeutic area, company, technology)
  • Sales (for marketed antibodies, peptides and proteins)
  • R&D Phase (clinical phases, market, preclinical)
  • Territory (countrywise)
  • Therapeutic Area (e.g. infectious, oncology, gastrointestinal)
  • Drug Code/Name (for individual molecules)

Each project is specified for its Target, Therapeutic Area and R&D Phase. Use of the R&D Drug Pipeline Database is intuitive. Data sets of interest can be printed and exported as reports in Excel or Word format. Projects are being updated continuously. The R&D history of each project with online references of information sources can be viewed and printed. Sales figures of major therapeutic antibodies, proteins and peptides on the market are provided.

An advanced search function allows to combine search parameters. A scroll down menu for predefined targets and technologies conveniently selects projects of interest. By clicking on column heads of the project list, projects can be arranged in ascending or descending alphabetical or numerical order, e.g. for phase or company name.

Special Focus of the Database:

  • Immuno-Oncology
  • Biosimilars
  • Antibodies
  • mRNA
  • Engineered Cells
  • Oncolytic viruses
  • Therapeutic Proteins
  • Peptides
  • Vaccines

Prerequisite: Internet access.

Purchase of the subscription provides a 1-year online access to the data of the R&D Drug Pipeline Database. Credentials to access the database will be sent by e-mail within 24 hours after purchase.

Benefits from the R&D Drug Pipeline Database:

  • Intuitive use
  • 24/7 online access
  • Designed for structured searches
  • Focused on targets, product categories and R&D phases
  • Ideal for competitor analysis (companies, targets, product categories)
  • Cost-effective and rapid solution for benchmarking
  • Identification of licensing candidates

Project listing in a tabular format:

  • Drug Codes
  • Target / Mechanism of Action
  • Class of Compound
  • Product Category
  • Company
  • Territory
  • Therapeutic Area
  • Indication
  • R&D Phase

Product Categories:

  • Antibody
  • Cell
  • DNA
  • Peptide
  • Protein
  • RNA
  • Small Molecule
  • Vaccine

Therapeutic Areas:

  • Cardiovascular, blood & acute care
  • Dermatology
  • Gastrointestinal
  • Genitourinary, gynecology & renal
  • Infectious & toxicology
  • Metabolism & endocrine
  • Neurology & psychiatry
  • Oncology
  • Ophthalmolgoy & otorhinolaryngology
  • Orthopedics, dental, anesthesia & surgery
  • Pulmonary & respiratory
  • Rheumatoid & autoimmune

Examples of Predefined Targets of the Scroll Down Menu:

  • Antibody-Drug Conjugates (ADC)
  • Sales of Antibodies & Proteins 2017
  • Intracellular targets (MAGE-A, NY-ESO-1, PRAME etc)
  • Immuno-oncology targets (PD-1, PD-L1, CTLA-4, LAG-3,TIM-3, 4-1BB, CD73 etc)
  • CAR & TCR Engineered T-Cells and NK Cells
  • Adalimumab (Humira) Biosimilars
  • Her2 Antibodies
  • Bispecific Antibodies
  • Oncolytic Viruses (adenovirus, vaccinia, HSV etc)
  • Ebola Virus Vaccines & Therapeutics
  • Coagulation Factors
  • Botulinum Neurotoxins
  • PTH-R Agonists
  • Cardiometabolic Peptides

Examples of Predefined Technologies of the Scroll Down Menu:

  • Transgenic XenoMouse Antibodies
  • T-Cell Redirecting Bispecific Antibodies
  • Agonistic Antibodies
  • TCR-like Antibodies & Fusion Proteins
  • ADC - Pyrrolobenzodiazepine (PBD)
  • Fc-Fusion Proteins
  • Oligo- and Polyclonal Antibodies

Sample Screenshots of R&D Drug Pipeline Database
as of November 12, 2014.